Glenmark Pharma shares jump nearly 9% on DCGI…

New Delhi: Shares of Glenmark Pharmaceuticals on Thursday gained nearly 9 per cent after the company said it has received approval from DCGI to conduct clinical trials of tablets used for the treatment of COVID-19…

Next Avenue: The science behind why older immune…

This article is reprinted by permission from NextAvenue.org. This “Ask the Expert” article is part of an editorial partnership between Next Avenue and The American Federation for Aging Research (AFAR), a national nonprofit organization whose mission is…